失眠症治療的全球市場:成長，趨勢，及預測

本報告提供全球失眠症治療市場的相關調查，市場機會和課題，成長及阻礙因素，各治療類型、流通管道、地區的市場分析，競爭情形，主要企業的簡介等資訊。

目錄

第1章 簡介

• 調查成果
• 調查的假設
• 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

• 市場概況
• 成長要素
• 阻礙因素
• 波特的五力分析
  • 新加入廠商的威脅
  • 買主/消費者談判力
  • 供應商談判力
  • 替代產品的威脅
  • 產業內的競爭

第5章 市場區隔

• 各治療類型
  • 苯重氮基鹽
  • Non苯重氮基鹽
  • 抗憂鬱症藥
  • Orexin拮抗劑
  • 褪黑激素拮抗劑
  • 其他
• 各流通管道
• 各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲地區
  • 南美

第6章 競爭情形

• 企業簡介
  • Merck & Co.
  • Mylan N.V.
  • Paratek Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • 大日本住友製藥株式會社
  • 武田藥品工業株式會社
  • Teva Pharmaceutical Industries Ltd.
  • Vanda Pharmaceuticals Inc.

第7章 市場機會及未來趨勢

The global insomnia treatment market is expected to grow at a CAGR of 5.3% over the forecast period. Increasing prevalence of insomnia across the world, rising stress level, growing geriatric population, and increasing awareness about various treatment options for this condition are some of the factors expected to propel the market.

Development of new technologies and introduction of medical devices are anticipated to boost market growth. Only few medical devices have been approved in the recent years such as EBB Insomnia Therapy, Fisher Wallace Stimulator, and Alpha-Stim AID, which are expected to have higher penetration due to favorable reimbursement policies and adoption of device - drug combination therapies for treating insomnia.

The other factors such as side effects due to certain OTC and prescription medication, arthritis, high usage of media devices before sleep, are driving the number of people suffering from insomnia, thus boosting the market growth prospects. Moreover, the growth of psychological conditions and constantly increasing noise levels in the urban areas will also propel the insomnia treatment market, during the forecast period.

Key Market Trends

Orexin Antagonist segment is expected to grow in the forecast period

The global insomnia treatment market is segmented based on treatment type, which includes benzodiazepines, nonbenzodiazepines, antidepressants, orexin antagonist, melatonin antagonist, and other treatment types. The distribution channel includes hospital pharmacies, retail pharmacies and drug stores, and online pharmacies.

The insomnia drugs comprise of a wide range of patented drugs, as well as generics. The patented drugs hold a larger share in developed regions, owing to the better reimbursement policies. The orexin antagonist segment is expected to grow rapidly during the forecast period due to its greater efficacy than other drugs.

North America is expected to dominate the Insomnia Treatment market

North America leads the insomnia treatment market. The growing need for sleep disorder treatment in the US and Canada coupled with the growing prevalence of sleep disorders is driving the market over the forecast period. Along with this, the rise in awareness and high health care spending are also expected to drive the market. Other factors that will promote the demand for insomnia drugs includes rapidly growing geriatric population and rising prevalence of sleep disorders and stress.

Competitive Landscape

The insomnia treatment market is fragmented in nature owing to the presence of multiple generic manufacturers. A few players operating in the market offer branded drugs options, however, price sensitivity is an issue in several emerging regions. Additionally, major manufacturers are focusing on the development of new molecules to gain a competitive edge and tap the high unmet needs in the market. The major players in the market are Merck & Co., Mylan N.V., Paratek Pharmaceuticals, Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Ltd., Teva Pharmaceutical Industries Ltd., and Vanda Pharmaceuticals Inc.

Reasons to Purchase this report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Table of Contents

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Stress Due to Highly Active Lifestyle of Individuals
  • 4.2.2 Side Effects Due to Certain OTC and Prescription Medication
  • 4.2.3 High Usage of Media Devices before Sleep
• 4.3 Market Restraints
  • 4.3.1 Misconceptions about the Seriousness of Insomnia
  • 4.3.2 Patient Non-Adherence due to Characteristic Side Effects of Insomnia Drugs
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Treatment Type
  • 5.1.1 By Drug
    • 5.1.1.1 Benzodiazepines
    • 5.1.1.2 Nonbenzodiazepines
    • 5.1.1.3 Antidepressants
    • 5.1.1.4 Orexin Antagonist
    • 5.1.1.5 Melatonin Antagonist
    • 5.1.1.6 Other Treatment
  • 5.1.2 Devices
• 5.2 By Distribution Channel
  • 5.2.1 Hospital Pharmacies
  • 5.2.2 Retail Pharmacies and Drug Stores
  • 5.2.3 Online Pharmacies
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Merck & Co.
  • 6.1.2 Mylan N.V.
  • 6.1.3 Paratek Pharmaceuticals, Inc.
  • 6.1.4 Pfizer Inc.
  • 6.1.5 Sanofi S.A.
  • 6.1.6 Sumitomo Dainippon Pharma Co., Ltd.
  • 6.1.7 Takeda Pharmaceutical Company Ltd.
  • 6.1.8 Teva Pharmaceutical Industries Ltd.
  • 6.1.9 Vanda Pharmaceuticals Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS